Experimental Study on Differentiation of Human Hepatocarcinoma Cells Induced by ligustri-astragali casein co-peptid Drug Serum in Vitro[J]. Chinese journal of experimental traditional medical formulae, 2008, 14(9): 47-50.
Experimental Study on Differentiation of Human Hepatocarcinoma Cells Induced by ligustri-astragali casein co-peptid Drug Serum in Vitro[J]. Chinese journal of experimental traditional medical formulae, 2008, 14(9): 47-50.DOI:
Objective: To study the effect of ligustri-astragali casein co-peptid(LACP)drug serum in inducing differentiation of Bel-7402 human hepatocarcinoma cell(HHC) and its influence of the telomerase activity.Methods: Rats were fed with LACP decoction to prepare the drug-serum of LACP
and the drug-serum was used for Bel-7402 HHC culture.Serum of normal rat
was taken as negative control and that of retinoic acid(RA) as the positive control.Cell proliferation was detected by MTT colorimetric assay
nucleocytoplasm ratio by image assay
α-fetoprotein(AFP) by RIA
alkaline phosphatase(ALP) activity and γ-glutamyl transpeptidase(γ-GT) by dynamic colorimetric assay and telomerase activity of Bel-7402 cell by PCR-ELISA.Results: Drug-serum of FACP could inhibit the proliferation of Bel-7402 cell
markedly reduce the nucleocytoplasm ratio and the secretion of AFP
decrease γ-GT activity
increase ALP activity and suppress the telomerase activity of Bel-7402 cell.Conclusion: LACP can induce the differentiation of Bel-7402 HHC
the main mechanism maybe throngh the suppression of telomerase activity.